Full Breakdown
CDC Faces Backlash Over New Hepatitis B Vaccine Policy
12/20/2025, 12:32:47 AM
Major Policy Shift on Hepatitis B Vaccination
The U.S. Centers for Disease Control and Prevention (CDC) has officially ended its long-standing recommendation that all newborns receive the hepatitis B vaccine within 24 hours of birth. This significant policy change, approved by Acting CDC Director Jim O’Neill, follows a vote from a reconstituted vaccine advisory panel appointed by Health Secretary Robert F. Kennedy Jr. The new guidance now advises parents of infants born to hepatitis B-negative mothers to consult healthcare providers regarding vaccination, potentially delaying the first dose until at least two months of age.
This shift marks a departure from over three decades of established medical practice, which had recommended universal vaccination for infants against hepatitis B since 1991. Public health experts have expressed concern that this change could lead to a resurgence of hepatitis B infections among children, as the vaccine has been credited with a nearly 90% reduction in cases since its widespread adoption.
Concerns from Public Health Experts
Critics of the new policy argue that it undermines decades of scientific consensus on the safety and efficacy of the hepatitis B vaccine. Sandra Adamson Fryhofer, a trustee of the American Medical Association, stated, “Rolling back this recommendation creates confusion and doubt about vaccines, reverses hard-won progress in preventing hepatitis B, and will undoubtedly result in completely preventable illness and death.” Similarly, Sen. Bill Cassidy (R-La.), a liver doctor, warned that the decision could make America sicker, emphasizing the risks of delaying vaccination.
Experts fear that the new recommendation, described by the CDC as “individual-based decision-making,” may lead to more families opting out of vaccination altogether, particularly in the absence of a firm federal policy. Michaela Jackson, program director at the Hepatitis B Foundation, noted that the change could create barriers to access and trust in public health guidance.
Official Statements & Responses
In response to the backlash, a CDC spokesperson stated that the agency remains committed to processing reasonable accommodation requests as quickly as possible and emphasized that interim accommodations, including telework, may be provided while cases move through the reasonable accommodation process. HHS Press Secretary Emily Hilliard reiterated that the department is dedicated to ensuring compliance with federal disability laws.
Senators Tim Kaine (D-Va.) and Raphael Warnock (D-Ga.) expressed their concerns in a letter, stating that the new policy “will inflict outsized harm on workers with disabilities,” highlighting specific cases where employees faced adverse health consequences due to the policy changes.
Conflicting Reports & Gaps
While the CDC maintains that the new policy reflects a balance of informed consent, critics argue that it disregards established medical evidence. The agency's decision has sparked a broader debate about the direction of public health policy under the current administration, particularly regarding vaccination and disability accommodations.
As the CDC navigates these contentious changes, the implications for public health and employee rights remain a focal point of discussion among lawmakers, health professionals, and the public.
